Hot Flash Clinical Trials

Are you a woman experiencing menopause? If so you may be facing the unpleasant symptoms of hot flashes and night sweats. These are some of the symptoms of menopause that pharmaceutical companies are trying to specifically find treatments for. Horizons Clinical Research Center, LLC often conducts studies for these new ...

Hot flashes are the most frequent symptom of menopause and may be related to changes in circulation. Hot flashes occur when the blood vessels near the skin's surface dilate to cool. They may be accompanied by a red, flushed face; sweating; rapid heart rate; and chills. The severity and duration ...

Clinical Research of Philadelphia is conducting a clinical research study of an investigational non-hormonal medication for hot flashes. Qualified participants may receive study related exams and study medication. Women 45 to 65 who have not had a period for at least six months and who experience hot flashes may qualify. ...

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

If so, you may be eligible to participate in a clinical research study to test the safety and effectiveness of an investigational medication, which is taken by mouth, in women who are experiencing moderate to severe vasomotor symptoms, commonly called hot flashes, associated with menopause. Give us a call or ...

Participation in clinical research studies is critical to the development of new standards of care. At TUCC, our research department is proud to provide patients with access to tomorrow’s urologic therapies today.  

This study is a randomized, placebo-controlled study of desvenlafaxine versus placebo. The purpose of this study is to determine if desvenlafaxine was effective in decreasing the frequency and severity of hot flashes in breast cancer patients taking tamoxifen.

There has been considerable interest in developing new treatment strategies for managing hot flashes among women with breast cancer, in view of the limitations associated with currently available treatments. This randomized study evaluates the safety and efficacy of 3 weeks of solifenacin compared to 3 weeks of clonidine, for women ...

50 menopausal women with the diagnosis of hot flushes were randomized to 1 of 2 groups Group (A): It consists of 25 women who practiced treadmill exercise program for 30 minutes at 60% to 70% of maximum heart rate. The treatment sessions will be repeated 3 times per week for ...

OBJECTIVES Primary Compare the progression-free survival and overall survival of patients with locally advanced or metastatic prostate cancer treated with transcutaneous estrogen patches vs luteinizing hormone-releasing hormone analogues. Secondary Compare the cardiovascular system-related morbidity and mortality in patients treated with these regimens Compare the activity of these treatments, in terms ...